BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 8246909)

  • 1. Antihelicase action of DNA-binding anticancer agents: relationship to guanosine-cytidine intercalator binding.
    Bachur NR; Johnson R; Yu F; Hickey R; Applegren N; Malkas L
    Mol Pharmacol; 1993 Nov; 44(5):1064-9. PubMed ID: 8246909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicase inhibition by anthracycline anticancer agents.
    Bachur NR; Yu F; Johnson R; Hickey R; Wu Y; Malkas L
    Mol Pharmacol; 1992 Jun; 41(6):993-8. PubMed ID: 1614415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.
    Robinson H; Priebe W; Chaires JB; Wang AH
    Biochemistry; 1997 Jul; 36(29):8663-70. PubMed ID: 9289011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solution structure of the calicheamicin gamma 1I-DNA complex.
    Kumar RA; Ikemoto N; Patel DJ
    J Mol Biol; 1997 Jan; 265(2):187-201. PubMed ID: 9020982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA helicase, ATPase and DNA-binding activities of E. coli RecQ helicase by chemotherapeutic agents.
    Zhang B; Zhang AH; Chen L; Xi XG
    J Biochem; 2008 Jun; 143(6):773-9. PubMed ID: 18296713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simian virus 40 large T-antigen G-quadruplex DNA helicase inhibition by G-quadruplex DNA-interactive agents.
    Tuesuwan B; Kern JT; Thomas PW; Rodriguez M; Li J; David WM; Kerwin SM
    Biochemistry; 2008 Feb; 47(7):1896-909. PubMed ID: 18205402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA recognition by intercalators and hybrid molecules.
    Waring MJ; Bailly C
    J Mol Recognit; 1994 Jun; 7(2):109-22. PubMed ID: 7826671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bis-benzimidazole anticancer agents: targeting human tumour helicases.
    Soderlind KJ; Gorodetsky B; Singh AK; Bachur NR; Miller GG; Lown JW
    Anticancer Drug Des; 1999 Feb; 14(1):19-36. PubMed ID: 10363025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihelicase action of CI-958, a new drug for prostate cancer.
    Lun L; Sun PM; Trubey CM; Bachur NR
    Cancer Chemother Pharmacol; 1998; 42(6):447-53. PubMed ID: 9788570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of intercalator binding on DNA triplex stability: correlation with effects on A-tract duplex structure.
    Sandström K; Wärmländer S; Bergman J; Engqvist R; Leijon M; Gräslund A
    J Mol Recognit; 2004; 17(4):277-85. PubMed ID: 15227636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design of a new bisintercalating anthracycline antibiotic.
    Chaires JB; Leng F; Przewloka T; Fokt I; Ling YH; Perez-Soler R; Priebe W
    J Med Chem; 1997 Jan; 40(3):261-6. PubMed ID: 9022792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actinomycin D specifically inhibits the interaction between transcription factor Sp1 and its binding site.
    Czyz M; Gniazdowski M
    Acta Biochim Pol; 1998; 45(1):67-73. PubMed ID: 9701497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of daunomycin to diaminopurine- and/or inosine-substituted DNA.
    Bailly C; Suh D; Waring MJ; Chaires JB
    Biochemistry; 1998 Jan; 37(4):1033-45. PubMed ID: 9454594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of the antitumor drug nogalamycin to bulged DNA structures.
    Caceres-Cortes J; Wang AH
    Biochemistry; 1996 Jan; 35(2):616-25. PubMed ID: 8555235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal tail domains of core histones in nucleosome block the access of anticancer drugs, mithramycin and daunomycin, to the nucleosomal DNA.
    Mir MA; Das S; Dasgupta D
    Biophys Chem; 2004 Apr; 109(1):121-35. PubMed ID: 15059665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
    Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; Braña MF; Bailly C
    Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultratight DNA binding of a new bisintercalating anthracycline antibiotic.
    Leng F; Priebe W; Chaires JB
    Biochemistry; 1998 Feb; 37(7):1743-53. PubMed ID: 9485299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolones.
    Ali SH; Chandraker A; DeCaprio JA
    Antivir Ther; 2007; 12(1):1-6. PubMed ID: 17503741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of microscopic binding constants at individual DNA base sequences for the minor groove binders Hoechst 33258, DAPI and pentamidine.
    Matesoi D; Kittler L; Bell A; Unger E; Lober G
    Biochem Mol Biol Int; 1996 Feb; 38(1):123-32. PubMed ID: 8932526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.